Victor Van Puyenbroeck

Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens

Yves Briers, Maarten Walmagh, Victor Van Puyenbroeck et al. · mBio · 2014 · 387 citations · Full text

Engineering, Microbial Pathogens, Bacteriophage +17

Signal Peptide-Binding Drug as a Selective Inhibitor of Co-Translational Protein Translocation

Kurt Vermeire, Thomas W. Bell, Victor Van Puyenbroeck et al. · PLoS Biology · 2014 · 58 citations · Full text

Molecular Biology, Cellular Physiology, Selective Human Cd4 +19

Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies

Reena Chawla, Victor Van Puyenbroeck, Nicholas C. Pflug et al. · Journal of Medicinal Chemistry · 2016 · 26 citations · Full text

Drug Target, Immunology, Chemical Biology +22

A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA)

Victor Van Puyenbroeck, Elisa Claeys, Dominique Schols et al. · Molecular & Cellular Proteomics · 2016 · 23 citations · Full text

Preprotein signature for full susceptibility to the co‐translational translocation inhibitor cyclotriazadisulfonamide

Victor Van Puyenbroeck, Eva Pauwels, Becky Provinciael et al. · Traffic · 2019 · 17 citations · Full text

Drug Target, Hucd4 Sp, Protein Assembly +25